These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3806373)

  • 1. Pharmacokinetic transfer functions and generalized clearances.
    Siegel RA
    J Pharmacokinet Biopharm; 1986 Oct; 14(5):511-21. PubMed ID: 3806373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug dosage in renal disease.
    Dettli L
    Clin Pharmacokinet; 1976; 1(2):126-34. PubMed ID: 797495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating reduced availability due to first pass elimination from relative total clearance and renal clearance.
    Brockmeier D
    Eur J Clin Pharmacol; 1988; 35(4):397-400. PubMed ID: 3197748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin as an active metabolizing barrier I: Theoretical analysis of topical bioavailability.
    Ando HY; Ho NF; Higuchi WI
    J Pharm Sci; 1977 Nov; 66(11):1525-8. PubMed ID: 915724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The physiological significance of total body clearance in pharmacokinetic studies.
    Chiou WL
    J Clin Hosp Pharm; 1982 Mar; 7(1):25-30. PubMed ID: 7096575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New calculation method of mean total body clearance of drugs and its application to dosage regimens.
    Chiou WL
    J Pharm Sci; 1980 Jan; 69(1):90-1. PubMed ID: 7354453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioavailability under variable renal clearance conditions.
    Oie S; Jung D
    J Pharm Sci; 1979 Jan; 68(1):128-9. PubMed ID: 758455
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug metabolite kinetics.
    Houston JB
    Pharmacol Ther; 1981; 15(3):521-52. PubMed ID: 7048351
    [No Abstract]   [Full Text] [Related]  

  • 9. Estimation of absolute bioavailability assuming steady state apparent volume of distribution remains constant.
    Collier PS; Riegelman S
    J Pharmacokinet Biopharm; 1983 Apr; 11(2):205-14. PubMed ID: 6886975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling the drug transport in the anterior segment of the eye.
    Avtar R; Tandon D
    Eur J Pharm Sci; 2008 Oct; 35(3):175-82. PubMed ID: 18662774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous absorption.
    Brisson P
    Can Med Assoc J; 1974 May; 110(10):1182-5. PubMed ID: 4597976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steady-state plasma concentrations as a function of the absorption rate and dosing interval for drugs exhibiting concentration-dependent clearance: consequences for phenytoin therapy.
    Sawchuk RJ; Rector TS
    J Pharmacokinet Biopharm; 1979 Dec; 7(6):543-55. PubMed ID: 529023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interplay of transporters and enzymes in drug and metabolite processing.
    Pang KS; Maeng HJ; Fan J
    Mol Pharm; 2009; 6(6):1734-55. PubMed ID: 19891494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membrane transport in hepatic clearance of drugs. I: Extended hepatic clearance models incorporating concentration-dependent transport and elimination processes.
    Kwon Y; Morris ME
    Pharm Res; 1997 Jun; 14(6):774-9. PubMed ID: 9210196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of diffusional barriers on drug and metabolite kinetics.
    de Lannoy IA; Pang KS
    Drug Metab Dispos; 1987; 15(1):51-8. PubMed ID: 2881759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The area under the curve of metabolites for drugs and metabolites cleared by the liver and extrahepatic organs. Its dependence on the administration route of precursor drug.
    Klippert PJ; Noordhoek J
    Drug Metab Dispos; 1985; 13(1):97-101. PubMed ID: 2858385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In situ artificial membrane permeation assay under hydrodynamic control: correlation between drug in vitro permeability and fraction absorbed in humans.
    Velický M; Tam KY; Dryfe RA
    Eur J Pharm Sci; 2011 Oct; 44(3):299-309. PubMed ID: 21864679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Theoretical relationships between area under the curve and route of administration of drugs and their precursors for evaluating sites and pathways of metabolism.
    Pang KS; Gillette JR
    J Pharm Sci; 1978 May; 67(5):703-4. PubMed ID: 641815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Method for the rapid estimation of the total body drug clearance and adjustment of dosage regimens in patients during a constant-rate intravenous infusion.
    Chiou WL; Gadalla MA; Peng GW
    J Pharmacokinet Biopharm; 1978 Apr; 6(2):135-51. PubMed ID: 671220
    [No Abstract]   [Full Text] [Related]  

  • 20. A convenient method for estimating the quantity of drug eliminated by the routes other than hepatic metabolism and renal excretion and the fraction of drug that reaches the "first pass" after oral administration.
    Berezhkovskiy LM
    J Pharm Sci; 2006 Apr; 95(4):828-33. PubMed ID: 16489605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.